Literature DB >> 18705916

Outline of the Japanese Guidelines for the Management of Stroke 2004 and subsequent revision.

Yukito Shinohara1, Takenori Yamaguchi.   

Abstract

The "Japanese Guidelines for the Management of Stroke" (chaired by Yukito Shinohara) appeared in 2004, in Japanese, as a result of the collaboration of the Japan Stroke Society, Japanese Society of Neurology, Japan Neurosurgical Society, Japanese Society of Neurological Therapeutics and the Japanese Association of Rehabilitation Medicine. During its preparation, 106 stroke specialists from these societies checked and rated more than 110,000 publications from all over the world, including Japan. We thought it important to develop specific guidelines for Japanese patients, because there are race differences, because some of the approved drugs in Japan are different from those in other counties, and because reports published in Japanese have not been taken into consideration in the development of western guidelines. We also added the Japanese guidelines for use of t-PA in this outline, because there are some differences (e.g., in volume of t-PA) from the guidelines of western countries. Here, we present an outline the Japanese Guidelines for the Management of Stroke 2004 in response to requests, although some updating is already needed. The first revision of the guidelines is expected to be completed in 2008.

Entities:  

Mesh:

Year:  2008        PMID: 18705916     DOI: 10.1111/j.1747-4949.2008.00178.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  22 in total

1.  Influence of previous physical activity on the outcome of patients treated by thrombolytic therapy for stroke.

Authors:  Amélie Decourcelle; Solène Moulin; Igor Sibon; Kei Murao; Thomas Ronzière; Olivier Godefroy; Mathilde Poli; Charlotte Cordonnier; Sharmila Sagnier; Veronica Lassalle; Yasushi Okada; Jean-Louis Mas; Régis Bordet; Didier Leys
Journal:  J Neurol       Date:  2015-08-15       Impact factor: 4.849

2.  Reliability of the skin blotting method when used on the elderly.

Authors:  Yuiko Koyano; Gojiro Nakagami; Takeo Minematsu; Hiromi Sanada
Journal:  Int Wound J       Date:  2018-06-13       Impact factor: 3.315

Review 3.  Antihypertensive therapy in acute ischemic stroke: where do we stand?

Authors:  Eleni Georgianou; Panagiotis I Georgianos; Konstantinos Petidis; Vasilios G Athyros; Pantelis A Sarafidis; Asterios Karagiannis
Journal:  J Hum Hypertens       Date:  2018-09-19       Impact factor: 3.012

4.  Significance of Development and Reversion of Collaterals on MRI in Early Neurologic Improvement and Long-Term Functional Outcome after Intravenous Thrombolysis for Ischemic Stroke.

Authors:  M Ichijo; E Iwasawa; Y Numasawa; K Miki; S Ishibashi; M Tomita; H Tomimitsu; T Kamata; H Fujigasaki; S Shintani; H Mizusawa
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-23       Impact factor: 3.825

Review 5.  Pharmacotherapy for the secondary prevention of stroke.

Authors:  Kazunori Toyoda
Journal:  Drugs       Date:  2009       Impact factor: 9.546

6.  Modified ASPECTS for DWI including deep white matter lesions predicts subsequent intracranial hemorrhage.

Authors:  Hiroyuki Kawano; Teruyuki Hirano; Makoto Nakajima; Yuichiro Inatomi; Toshiro Yonehara; Makoto Uchino
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

7.  Exercise protects bone after stroke, or does it? A narrative review of the evidence.

Authors:  Karen Borschmann
Journal:  Stroke Res Treat       Date:  2011-10-09

8.  Maximum preservation of the media in carotid endarterectomy.

Authors:  Kuniyasu Niizuma; Hiroaki Shimizu; Takashi Inoue; Mika Watanabe; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-09-29       Impact factor: 1.742

Review 9.  Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis.

Authors:  Wuxiang Xie; Fanfan Zheng; Baoliang Zhong; Xiaoyu Song
Journal:  J Am Heart Assoc       Date:  2015-08-24       Impact factor: 5.501

10.  Location of the Susceptibility Vessel Sign on T2*-Weighted MRI and Early Recanalization within 1 Hour after Tissue Plasminogen Activator Administration.

Authors:  Junya Aoki; Kazumi Kimura; Kensaku Shibazaki; Yuki Sakamoto; Naoki Saji; Junichi Uemura
Journal:  Cerebrovasc Dis Extra       Date:  2013-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.